Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Department of Clinical Medicine, Faculty of Health and Clinical Sciences, University of Copenhagen, Copenhagen, Denmark.
Thyroid. 2023 Nov;33(11):1287-1301. doi: 10.1089/thy.2023.0292. Epub 2023 Oct 18.
Thyroid autoimmunity is the most prevalent autoimmune disorder among women of reproductive age and has been suggested as a risk factor in recurrent pregnancy loss (RPL)-a condition in which couples suffer several consecutive pregnancy losses, but where a cause can be identified in less than half of the cases. Most studies have focused on thyroid peroxidase antibodies (TPOAbs), not considering the presence of thyroglobulin antibodies (TgAbs). The aim of this study was to systematically assess the prevalence of TgAb positivity in women with RPL, and whether TgAb positivity was associated with the outcome of the next pregnancy. A systematic literature search of PubMed and Embase (from inception to April 29, 2023) was performed for studies reporting on TgAbs in women with RPL. The primary outcome was TgAb positivity in women with RPL compared with women without RPL, with a secondary outcome of association between TgAb positivity and the outcome of the next pregnancy. Pooled effect estimates were expressed as odds ratios (ORs) with confidence intervals [CI] using a random-effects model. The study was registered with PROSPERO (No. CRD42022310232) and adhered to the PRISMA guidelines. A total of 770 studies were screened, 28 of which could be included reporting data from a total of 6868 women. The prevalence of TgAb positivity in women with RPL ranged from 3.6% to 28% compared with 2.4% to 29% in women without RPL. The OR for TgAb positivity was 1.93 ([CI 1.27-2.92]; = 63%) compared with women without RPL, and for TgAbs and/or TPOAbs 2.66 ([CI 1.75-4.05]; = 69%). Four studies reported on the outcome of the next pregnancy after antibody measurement with highly heterogeneous results (OR for pregnancy loss ranging from 0.99 in one study to 10.0 in the other study, and two studies reported no data eligible for meta-analysis). Consequently, a meta-analysis could not be performed. Women with RPL were significantly more often TgAb-positive than women without RPL. Although there was a lack of studies reporting prospective outcomes, the findings of this study support the significance of awareness about the strong association between RPL and thyroid autoimmunity.
甲状腺自身免疫是育龄妇女中最常见的自身免疫性疾病,被认为是复发性流产(RPL)的一个风险因素-这种情况下,夫妻会经历多次连续的妊娠丢失,但在不到一半的病例中可以确定病因。大多数研究都集中在甲状腺过氧化物酶抗体(TPOAbs)上,而没有考虑到甲状腺球蛋白抗体(TgAbs)的存在。本研究的目的是系统评估 RPL 妇女 TgAb 阳性的患病率,以及 TgAb 阳性是否与下一次妊娠的结局相关。 对 PubMed 和 Embase 进行了系统的文献检索(从建立到 2023 年 4 月 29 日),以检索报告 RPL 妇女 TgAbs 的研究。主要结局是 RPL 妇女 TgAb 阳性与无 RPL 妇女 TgAb 阳性的比较,次要结局是 TgAb 阳性与下一次妊娠结局的关系。使用随机效应模型,以比值比(ORs)和置信区间[CI]表示汇总效应估计值。该研究已在 PROSPERO(编号:CRD42022310232)上注册,并遵循 PRISMA 指南。 共筛选了 770 项研究,其中 28 项符合纳入标准,共纳入了 6868 名妇女的数据。与无 RPL 的妇女相比,RPL 妇女的 TgAb 阳性率为 3.6%至 28%,而无 RPL 的妇女为 2.4%至 29%。与无 RPL 的妇女相比,TgAb 阳性的 OR 为 1.93([CI 1.27-2.92];=63%),而 TgAbs 和/或 TPOAbs 的 OR 为 2.66([CI 1.75-4.05];=69%)。四项研究报告了抗体测量后下一次妊娠的结局,但结果高度异质(一项研究中妊娠丢失的 OR 从 0.99 到另一项研究中的 10.0,两项研究报告没有符合荟萃分析的数据)。因此,无法进行荟萃分析。 RPL 妇女 TgAb 阳性的发生率明显高于无 RPL 的妇女。尽管缺乏报告前瞻性结局的研究,但本研究的结果支持了 RPL 与甲状腺自身免疫之间存在强烈关联的重要性。